Target intelligence / Profile preview

TOX high mobility group box family member 2 (TOX2)

Target
TOX2
Molecular classification
Transcription factor, High mobility group (HMG) box family
01

Overview

TOX high mobility group box family member 2 (TOX2) is a protein-coding transcription factor of the high mobility group box (HMG-box) family. TOX2 binds chromatin and functions primarily in the nucleus as a regulator of gene expression, particularly in the positive regulation of transcription by RNA polymerase II. It is preferentially expressed in mature human natural killer (NK) cells and is essential for the late stages of human NK cell development, acting by specifically and directly upregulating the transcription of TBX21 (encoding T-BET), a master transcription factor critical for NK cell maturation and cytotoxic function. TOX2's expression pattern is largely distinct from other family members: it is expressed during later stages of NK cell maturation and not in early NK progenitors. Its deficiency impairs NK cell maturation, notably by reducing T-BET and perforin expression, suggesting a central role in immune homeostasis. TOX2 has also been reported to have expression in reproductive and neural tissues, and is associated with some disease phenotypes, notably cancer pathways (including clear cell renal cell carcinoma) and age-related macular degeneration. Its function as a transcription factor may provide future opportunities for therapeutic modulation, although it is not currently considered a direct therapeutic target for any known drugs.

Other names
C20orf100GCX1GCX-1dJ1108D11.2dJ495O3.1Granulosa cell HMG box protein 1granulosa cell HMG box 1
02

Biological functions

Regulation of transcriptionLymphocyte (specifically NK cell) developmentPositive regulation of transcription by RNA polymerase IIRegulation of T-BET (TBX21) expression
03

Disease associations

Cancer (notably clear cell renal cell carcinoma pathway involvement)Possible involvement in macular degenerationImmune cell dysfunction (especially NK cell-related abnormalities)

Beyond the preview

Go deeper on TOX high mobility group box family member 2 (TOX2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TOX high mobility group box family member 2 (TOX2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call